Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지

Clinical Outcomes of Multidisciplinary Team Care on the Regulation of Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) in Patients Undergoing Dialysis

미네랄 골질환 합병증을 가진 투석환자에서 다학제 팀 서비스의 임상적 성과

  • Han, Nayoung (College of Pharmacy, Chungnam National University) ;
  • Lee, Sang-Min (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Hong, Jin Yi (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Noh, Hye Jin (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Ji, Eunhee (College of Pharmacy, Gachon University) ;
  • Song, Yun-Kyoung (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Song, Jeeyoun (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Kim, In-Wha (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Kim, Yon Su (Division of Nephrology, Department of Internal Medicine, Seoul National University Hospital) ;
  • Oh, Jung Mi (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
  • Received : 2016.11.18
  • Accepted : 2016.12.14
  • Published : 2016.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Multidisciplinary team care (MTC) is a collaborative approach to treatment plan and ongoing care. We aimed to evaluate the clinical effect of MTC on the regulation of chronic kidney disease-mineral and bone disorder (CKD-MBD) complications in dialysis patients. Methods: This retrospective observational study was approved by the institutional review board. Among patients who have undergone dialysis at admission, the patients admitted to the nephrology ward were allocated to MTC group, and the others to usual care (UC) group. The MTC group had collaborative care by nephrologists, nurses, pharmacists, and nutritionists. The endpoints were the regulation of corrected calcium (cCa) and phosphate (P), the percent of patients in target level of cCa-P product ($cCa{\times}P$), and the prescription rate of non-calcium based P-binders. Results: A total of 163 patients were included from January to December 2009. A significant difference was shown in the percentage of patients in target $cCa{\times}P$ level at admission (MTC vs. UC, 81.40% vs. 91.67%; P = 0.038), but there was no significant difference at discharge. During admission, the cCa and P levels of patients in only UC group were significantly changed. In addition, compared with UC group, patients in MTC group were more likely prescribed appropriate P-binders, when they had higher $cCa{\times}P$ levels than $55mg^2/dL^2$ (P <0.001). Conclusion: It was found that MTC had beneficial effect on improving the regulation of CKD-MBD and the appropriate phosphate binder uses. Therefore, application of the MTC is anticipated to enhance quality of clinical care in chronic diseases.

Keywords

References

  1. Makowsky MJ, Schindel TJ, Rosenthal M, et al. Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical setting. J Interprof Care 2009;23(2):169-84. https://doi.org/10.1080/13561820802602552
  2. 이병구. 우리나라 약사의 팀 의료 현황과 활성화 방안. J Kor Soc Health-Syst Pharm 2008;25(2):89-95.
  3. Yarnall KSH, Ostbye T, Krause KM, et al. Family physicians as team leaders: "time" to share the care. Prev Chronic Dis 2009; 6. Available from http://www.cdc.gov/pcd/issues/2009/apr/08_0023.htm. Accessed December 18, 2010.
  4. Carter BL, Doucette WR, Franciscus CL, et al. Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention. Pharmacotherapy 2010;30(3):228-35. https://doi.org/10.1592/phco.30.3.228
  5. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009;169(21):1996-2002. https://doi.org/10.1001/archinternmed.2009.358
  6. Carter BL, Rogers M, Daly J, et al. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med 2009; 169(19):1748-55. https://doi.org/10.1001/archinternmed.2009.316
  7. Kohn LT, Institute of Medicine. Academic Health Centers: Leading Change in the 21st Century. Washington, DC: The National Academy Press 2003:65-76.
  8. Institute of Medicine (US) Committee on the Health Professions Education Summit; Greiner AC, Knebel E, editors. Health Professions Education: A Bridge to Quality. Washington (DC): National Academies Press (US); 2003. Chapter 3, The Core Competencies Needed for Health Care Professionals. Available from https://www.ncbi.nlm.nih.gov/books/NBK 21519.
  9. Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31:607-17. https://doi.org/10.1053/ajkd.1998.v31.pm9531176
  10. Hruska KA and Teitelbaum SL. Renal osteodystrophy. N Engl J Med 1995;333:166-74. https://doi.org/10.1056/NEJM199507203330307
  11. Martin KJ and Gonzalez EA. Metabolic bone disease in chronic kidney disease. J Am Soc Nephrol 2007;18:875-85. https://doi.org/10.1681/ASN.2006070771
  12. Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938-42. https://doi.org/10.1161/hy1001.096358
  13. Haydar AA, Covic A, Colhoun H, et al. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 2004;65:1790-4. https://doi.org/10.1111/j.1523-1755.2004.00581.x
  14. Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 2006;70:351-7. https://doi.org/10.1038/sj.ki.5001542
  15. Noordzij M, Korevaar JC, Bos WJ, et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant 2006; 2513-20.
  16. Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69:1945-53. https://doi.org/10.1038/sj.ki.5000414
  17. Unruh ML, Evans IV, Fink NE, et al. Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients. Am J Kidney Dis 2005;46:1107-16. https://doi.org/10.1053/j.ajkd.2005.09.002
  18. Goldstein M, Yassa T, Dacouris N, et al. Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis 2004;44(4):706-14. https://doi.org/10.1016/S0272-6386(04)00940-0
  19. Pai AB, Boyd A, Depczynski J, et al. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study. Pharmacotherapy 2009;29(12):1433-40. https://doi.org/10.1592/phco.29.12.1433
  20. Koechler JA, Abramowitz PW, Swim SE, et al. Indicators for the selection of ambulaory patients who warrant pharmacist monitoring. Am J Hosp Pharm 1989;46:729-32.
  21. Manley HJ, Cannella CA, Bailie GR, et al. Medication-related problem in ambulatory hemodialysis patients: A pooled analysis. Am J Kidney Dis 2005;46(4):669-80. https://doi.org/10.1053/j.ajkd.2005.07.001
  22. Strand LM, Morley PC, Cipolle RJ, et al. Drug-related problems: their structure and function. DICP 1990;24:1093-7. https://doi.org/10.1177/106002809002401114
  23. International Society of Nephrology. KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int 2009;76(113):S1-132.
  24. Sesso R and Belasco AG. Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant 1996;11:2417-20. https://doi.org/10.1093/oxfordjournals.ndt.a027207
  25. Levin NW and Hoenich NA. Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr Opin Nephrol Hypertens 2001;10:563-8. https://doi.org/10.1097/00041552-200109000-00003
  26. Friedman O, Wald R, Goldstein MB. The impact of prior multidisciplinary predialysis care on mineral metabolic control among chronic hemodialysis patients. Nephron Clin Pract 2008;110:c229-34. https://doi.org/10.1159/000167870
  27. Rasgon SA, Chemleski BL, Ho S, et al. Benefits of a multidisciplinary predialysis program in maintaining employment among patients on home dialysis. Adv Perit Dial 1996;12:132-5.
  28. Obrador GT, Arora P, Kausz AT, et al. Pre-end-stage renal disease care in the United States: a state of disrepair. J Am Soc Nephrol 1998;9:S44-54.